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Abstract: Objective: To report a case of vertical herpetic meningoencephalitis. Results: The involvement of the 
central nervous system (CNS) in infection by HSV (herpes simplex virus), HSV-1 or HSV-2, causes an acute 
inflammatory process in the brain parenchyma, leading to herpetic encephalitis. It is a feared form of the disease 
due to its severity and its high rate of morbidity and mortality. Its rapid fatal progression can be prevented from 
early suspicion and treatment, which is essential when taking into account their neurological sequelae since 
survivors have motor sequelae, behavioral disorders, or epilepsy. The present work reports the case of a newborn 
male with spontaneous vaginal delivery who, at 19 days of age, started to experience fever, irritability, difficulty in 
eating, spasms, tremors of the upper limbs, deviation of the eyes, and seizures of difficult to control, together with 
CFE and serological changes, in addition to imaging tests compatible with herpetic meningoencephalitis, 
progressing with a very serious evolution despite the institution of specific treatment for CNS herpetic infection, 
evolving with important neurological sequelae. Conclusion: The sequels resulting from herpetic encephalitis not 
properly diagnosed, or even late, leads from severe neurological damage to death. Therefore, it is extremely 
important to start empirical treatment with antiviral drugs to reduce the sequelae mentioned above. 
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1. Introduction 
 During pregnancy, pregnant women can be 
exposed to a variety of infectious agents, including 
viruses, bacteria, protozoa, or fungi [1]. These 
infectious agents, when they affect the fetus, can 
cause important perinatal morbidity and mortality. The 
fetus can be affected during intrauterine life, or the 
baby can be infected during delivery or in the first 
weeks of life [1,2]. 
The most frequent congenital infections are 
toxoplasmosis, syphilis, acquired immunodeficiency 
virus, rubella, cytomegalovirus (CMV), and herpes 
simplex virus (HSV). The agents most involved in 
congenital infections are viruses, with HSV being the 
largest pathogenic group for men [3]. In the case of 
HSV infection, the vast majority of vertical transmission 
occurs in the intrapartum period [4]. 
Neonatal HSV infections are uncommon. In 
contrast, infections by genital herpes in adults are very 
common [5,6]. Therefore, it is not uncommon to 
manage babies who may be exposed to HVS during 
delivery, making it essential to prevent the potentially 
devastating consequences of neonatal virus disease [7-
9]. During pregnancy, the most common form of HSV 
is through recurrent infections [10]. According to 
American statistical data, approximately 10% of 
women who do not have HSV-2 have a sexual partner 
who carries this virus. Thus, these pregnant women 
are at risk of contracting a primary HSV-2 infection 
during pregnancy and thus transmitting the virus to 
the fetus [11]. 
Transmission of HSV-2 generally occurs 
through sexual intercourse. This virus can cause 
neurological syndromes such as meningitis, especially 
recurrent, encephalitis, particularly in neonates, and 
lumbosacral radiculitis [10]. 
The involvement of the central nervous system 
(CNS) in infection by HSV, HSV-1, or HSV-2, causes an 
acute inflammatory process in the brain parenchyma, 
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leading to herpetic encephalitis [12,13]. The diagnostic 
method considered to be the gold standard is brain 
tissue biopsy, however, in practice, the diagnosis is 
made by clinical correlation with complementary tests 
such as fever, headache, decreased level of 
consciousness, cerebrospinal fluid examination (CFE), 
electroencephalogram (EEG) and brain nuclear 
magnetic resonance (NMR). Neurological deficits can 
still occur, such as focal deficits or seizures, amnesia, 
ataxia, or emotional lability [10,12,13]. 
Herpetic encephalitis is a disease feared due to 
its severity and its high rate of morbidity and mortality. 
Its rapid fatal progression can be prevented from early 
suspicion and treatment [13,14], which becomes 
essential when taking into account their neurological 
sequelae since survivors have motor sequelae, 
behavioral disorders, or epilepsy [15]. 
In this context, therefore, the present study 
presents the case of an infant male patient, diagnosed 
with herpes simplex virus infection of vertical 




The present study is a case report whose 
bibliographic research used the descriptors (MeSH 
Terms) herpes simplex, herpetic encephalitis, 
congenital infections. The research was carried out 
through the study of digital articles and virtual books 
attached to the PubMed, Embase, Ovid, Cochrane 
Library, Web Of Science, ScienceDirect Journals, 
Scopus, academic Google, in database platforms such 
as Scientific Electronic Library Online (SCIELO), 
PubMed, and in scientific repositories, following the 
rules of systematic review - PRISMA (Transparent 
reporting of systematic reviews and meta-analyzes-
HTTPS://www.prisma-statement.org/). Used as the 
main data sources, the most relevant works were 
selected for the theme for synthesis and presentation 
of information, excluding references that diverged 
from the purposes covered here. 
 
2.1 Case Report 
The present study was elaborated according to 
the rules of CARE case report (https://www.care-
statement.org/) [16]. The study data were obtained 
through the analysis and collection of information 
contained in the patient's medical record at the Norte 
Pioneiro Regional Hospital, located in Santo Antônio da 
Platina-PR. 
2.2 Patient Information and Clinical 
Findings 
PHFO, a newborn male, was born at 39 weeks 
on 02/19/2020 via spontaneous vaginal delivery, with 
no crying at birth, hypotonic, and with APGAR 7 and 9. 
Assistance was performed in the delivery room, with 
good response. and the NB was kept together until 
discharge after 48 hours. His mother did not report 
any complications during pregnancy, other than the 
treatment of an E. coli urinary tract infection (UTI) at 
the beginning of the gestational period. 
On 08/03/2020, with 19 days of life, the 
patient started a fever of 38 ºC at home, and for this 
reason, his mother sought the Emergency Room, 
where she was instructed to use Paracetamol for 6/6 
hours. The following day, in addition to the fever, he 
presented irritability, difficulty in eating, spasms, 
tremors of the upper limbs, deviation of the eyes, and 
convulsions. The same day he was admitted to the 
Regional Hospital of Norte Pioneiro, in Santo Antônio 
da Platina-PR, being requested a place in the Intensive 
Care Unit (ICU). On physical examination at the time 
of admission, the patient presented with pustular 
lesions in the neck region, and it was reported that the 
newborn was using Neomycin for 8/8 hours and 
Cephalexin for 6/6 hours for 6 days. 
After admission to the ICU, the newborn 
evolved into a state of epileptic malaise, with seizures 
that are difficult to control. It was necessary to use 
Phenobarbital up to 40 mg/kg intravenously and use 
Phenytoin. Even so, he presented convulsive crises, 
requiring the administration of Phenobarbital 14 mg/kg 
24 hours after the last dose of Phenobarbital. He 
evolved with significant sedation, without the need to 
intubate, but with the use of oxygen in the incubator. 
He used Phenobarbital 2.5 mg/kg for 48 hours through 
the gastric route and had Hidantal suspended. 
 
2.3 Timeline 
From birth (02/19/2020) to the present. 
 
2.4 Diagnostic Assessment 
Initially, the diagnostic hypothesis of bacterial 
meningitis was made, CSF collection was performed 
and treatment with Vancomycin and Cefepime was 
started. The result of the CFE analysis showed a 
slightly cloudy, light yellow CFE containing 307 red 
blood cells/mL, 49 leukocytes/mL, 12% neutrophils, 
1% eosinophils, 84% lymphocytes and 4% monocytes; 
glucose was 27 mg/dL, chlorides 118 mEq/L (within 
the normal range) and proteins 62 mg/dL. 
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Polymorphonuclear leukocytes were 13% and 
monomorphonuclear 87%. 
Even with the antibacterial treatment instituted 
for meningitis, the patient continued to present 
seizures, needing to be maintained with Phenobarbital 
5 mg/kg/day. Ophthalmology evaluation was 
requested and, due to the permanence of seizures, 
cranial CT was also requested. 
The ophthalmological evaluation found a retina 
of usual color, and optic nerve apparently without 
edema, a macular alteration in both eyes, and a slight 
vitreous opacity in the left eye. The reassessment after 
one week showed areas of macular hyperpigmentation 
in both eyes, a slight pallor of bilateral papillae, a left 
eye with pigment in the lens, and a hyperpigmented 
lesion in the peripheral retina. 
In cranial CT, an area of hypodensity was 
found, compromising the brain parenchyma in the 
topography of the anterior portions of the base nuclei 
and the thalamus bilaterally, which may correspond to 
ischemic hypoxic damage. Signs of subarachnoid and 
supratentorial hemorrhage have also been 
demonstrated, as well as hemorrhagic areas of the 
occipital and ventricular horns. 
The radiologist responsible for the newborn CT 
scan of the newborn observed signs that could suggest 
encephalitis as responsible for the condition, and from 
this suspicion, the diagnostic hypothesis of 
meningoencephalitis was raised, and serologies for 
herpes simplex, cytomegalovirus, toxoplasmosis, 
syphilis, and rubella. 
The serologies, all performed by the 
chemiluminescence method, were negative, except 
cytomegalovirus IgG - 81.70 AU/mL (reagent 
reference: ≥ 6.0 AU/mL), herpes 1 and 2 IgM> 3.5 
(reagent reference: ≥1.1), and herpes 1 and 2 IgG 
10.0 (reagent reference: ≥1.1). The positive result of 
serologies for herpes 1 and 2, added to the clinical 
picture of the newborn, closed the diagnosis of the 
case of herpetic meningoencephalitis. The CFE PCR 
diagnostic method was not performed due to the 
unavailability of the examination at the medical 
treatment center. 
 
2.5 Therapeutic Intervention and 
Follow-up  
The recommended treatment with intravenous 
Acyclovir was initiated for 21 days, with improvement 
in seizures and general conditions. However, the 
patient did not evolve with the full improvement of the 
neurological condition, remaining with sequelae of 
herpetic meningoencephalitis. With the evolution, the 
NB obtained remission of seizures with the use of 
Phenobarbital, but still had difficulty in feeding due to 
weak suction, which was still gradually improving. In 
continuity, he needed to perform a gastrostomy 
because he did not recover the suction and swallowing 
capacity. 
Because of the sequelae, the patient was 
referred to the specialties of Physiotherapy, 
Neuropediatrics, Pediatric Cardiology, Speech Therapy, 
and Ophthalmology to receive adequate long-term 
follow-up. 
 
2.6 Informed Consent 
Those responsible for the patient signed the 
consent form. 
 
2.7 Patient Perspective 
Those responsible for the patient in the 
present study have the perspective that the interaction 
of a multidisciplinary medical team will favor the 
resolution of illnesses and the progression to a stable 
condition of the patient. 
 
3. Discussion 
 Despite being rare, and with a prevalence of 
approximately 1%, congenital herpes simplex infection 
leads to high newborn morbidity and mortality [1,17]. 
Babies born to mothers with recent episodes of genital 
HSV infection are at a much higher risk of developing 
neonatal herpes [2,15]. 
The manifestations resulting from the infection 
can be cutaneomucosal, neurological, or disseminated 
[3]. In 50% of cases, the disseminated form occurs, 
with a mortality rate of 30%. The involvement of the 
nervous system can occur in isolation or disseminated 
forms, with the probability of neurological 
abnormalities or sequelae in more than 70% of the 
affected children [18-20]. 
Herpetic encephalitis consists of an acute 
process of the brain parenchyma, having a 
hemorrhagic necrotizing character, especially in the 
temporal-medial and frontal-basal regions. Encephalitis 
can progress quickly and end up having a fatal 
outcome in a matter of one to two weeks without 
treatment [4,13,20]. 
The newborn can have both HSV-1 and HSV-2 
infections. HSV-2 is the most commonly found 
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serotype is found in older reports, however, currently, 
literature reports that HSV-1 has played a more 
important role in neonates [13,21,22]. This infection is 
rare, and data from 2014 report its appearance in 
approximately 1 in 2000 to 5000 births. Of the possible 
transmission routes, intrauterine is the worst one 
because it generates teratogenic effects, such as skin 
lesions or scars, CNS disorders, and chorioretinitis 
[24,25]. As the mother was not tested for HSV 
serology or asked about any signs or symptoms, it was 
not possible to say with certainty whether intrauterine, 
perinatal, or postpartum transmission occurred. 
A nonspecific prodrome occurs in the initial 
infection, usually characterized by headache, fever, 
general malaise, vomiting, and behavioral deviations. 
Later on, focal neurological deficits appear, such as 
focal or generalized seizures, with olfactory or 
gustatory hallucinations and visual field disorders of 
the upper quadrant. Lethargy, irritability, poor diet, 
temperature instability, and bulging fontanelle can still 
be observed. Still, in 2/3 of the cases, skin lesions can 
occur, which alerts the diagnosis, since, in children 
with CNS disease, 60-70% have skin lesions at some 
point in the course of the disease [18,25]. 
Even with proper treatment, there can be 
severe neurological sequelae, including cortical 
hemorrhage, microcephaly, megacystic 
encephalomalacia with laminar necrosis, cortical 
atrophy and gliosis, subdural egromas, infratentorial 
hemorrhages or effusions, developmental delay, 
epilepsy, quadriplegia, and blindness [13,24]. One of 
the changes presented by the patient in question was 
the ophthalmology that maintains specialized 
monitoring, in addition to important neurological 
sequelae. 
CFE analysis should be requested in newborns 
who have fever, irritability, and seizures, and the 
negative result for HSV infection does not exclude the 
result initially. CFE analysis has great value and usually 
presents with pleocytosis (10 to 200 cells/mm3) with a 
predominance of mononuclear cells, normal or 
elevated glucose, and increased or slightly increased 
proteins [27,28]. The result of the CFE analysis of the 
patient of the case obtained pleocytosis of 49 cells/mL 
with a predominance of monomorphonuclear cells 
(87%), decreased glucose (27 mg/mL), and increased 
proteins (62 mg/dL). 
Among the tests that can be used to detect 
the virus, we can mention viral cultures of the 
oropharynx, nasopharynx, mucous swabs, rectal 
smear, leukogram, CFE PCR (viral DNA), skin lesions, 
mucous membranes, and blood; staining of 
immunofluorescent antibodies to skin lesions; enzyme 
immunoassays for HSV antigens in skin lesions [15]. In 
the case described, it was not possible to perform the 
diagnostic method by PCR, and instead, serology for 
HSV was performed, which showed reactants in more 
than one opportunity, closing the diagnosis. 
The specific serological examination can be 
used for retrospective diagnosis. It helps to assess 
whether mothers with no previous history of HSV 
infection have a primary infection in late pregnancy 
and have transferred little or no antibody to the fetus. 
Due to the inherent immaturity of the immune 
response to systemic viral infections in this age group, 
IgM production is delayed or does not occur in infected 
newborns [28]. The patient in question had a positive 
serological result for IgM infection, which helped to 
close the diagnosis of the case. This serological result 
may remain positive until one year of age. 
It is very important to consider that the use of 
PCR for HSV in the assessment of newborns will 
increase the length of hospital stay, the costs, and the 
risk of nosocomial infection. Even so, the CFE analysis 
of the cerebrospinal fluid is considered the gold 
standard and can be complemented by imaging tests 
such as CT, NMR, and EEG. Eventually, a brain biopsy 
may be ordered when clinical deterioration occurs 
despite treatment with acyclovir [27,29,30]. 
The diagnosis of the case in question, as well 
as in the literature, was based on the union of the 
clinic with the complementary exams. Thus, the 
combination of several factors pointed to the diagnosis 
of herpetic meningoencephalitides, such as the fact 
that the NB has a fever of 38 ºC, convulsions, tremors 
of the upper limbs, irritability, and deviation of the 
eyes added to the IgM and IgG serologies positive for 
HSV. 
For non-localized diseases, the currently 
recommended regimen is intravenous acyclovir (60 
mg/kg/day divided into 3 doses, ie 20 mg/kg every 8 
hours), for 14 days, and for disseminated and CNS 
disease the duration is 21 days. The shorter treatment 
time is related to the risk of reactivation and damage 
to the central nervous system. The early use of 
acyclovir reduces the percentage of CNS involvement 
and increases the number of non-localized diseases. 
High-dose antiviral can improve morbidity and restore 
normal development of the nervous system in 83% of 
survivors, but for children with diseases of the central 
nervous system, only 31% of survivors are so 
successful [12,18,24,26]. 
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It is recommended to start antiviral therapy 
within the first 4 days to avoid death and short-term 
complications and should be administered slowly to 
avoid nephrotoxicity. Therefore, due to the higher 
success rate of early administration, it is recommended 
to start the empirical treatment after the diagnosis is 
suspected until it is confirmed [15]. 
The treatment with acyclovir could not be 
started early in the case described due to the fact that 
the NB returned to the service only after 19 days of 
life, with symptoms of CNS involvement for some days. 
Even with the recommended treatment introduced, the 
patient ended up evolving with sequelae of herpetic 
meningoencephalitis. 
There is controversy about the patient who 
needs empirical therapy. There are recommendations, 
by some authors, in cases of specific signs of HSV and 
symptoms, such as seizures, vesicles, signs of sepsis, 
or pleocytosis in the analysis of CFE. Others consider 
empirical therapy only in neonates with symptoms 
started before 21 days of age [30]. 
 
4. Conclusion 
The sequelae resulting from herpetic 
encephalitis not properly diagnosed, or even late, leads 
from severe neurological damage to death. Therefore, 
it is of utmost importance to start the empirical 
treatment with the antiviral to reduce the sequels 
mentioned above. Although rare, HSV infection is 
extremely serious and, therefore, it becomes valid to 
adopt preventive measures during prenatal, delivery, 
and immediate postpartum. In addition, it is up to the 
doctor to investigate the past history of HSV in the 
pregnant woman and her sexual partner. The use of 
acyclovir is permitted in pregnant women over 36 
weeks of gestational age with primary infection or risk 
of recurrence. And the mode of delivery of choice in 
the presence of the active disease is cesarean. With 
hospital discharge, the puerperal woman should be 
advised about the importance of monitoring the child 
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